title: [Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].
authors: S
authors: S
authors: Obradović
authors: B
authors: B
authors: Gligić
authors: D
authors: D
authors: Djordjević
authors: A
authors: A
authors: Jovicić
authors: R
authors: R
authors: Romanović
authors: N
authors: N
authors: Ratković
authors: D
authors: D
authors: Dincić
authors: V
authors: V
authors: Orozović
authors: G
authors: G
authors: Nikolić
mesh_terms: D000077284:Abciximab; D000085:Acetates / Q000627:therapeutic use; D000789:Angina, Unstable / Q000188:drug therapy; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000077542:Eptifibatide; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000628:therapy; D010455:Peptides / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D000077466:Tirofiban; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000085:Acetates; D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; C084062:lamifiban; D000077466:Tirofiban; D000077542:Eptifibatide; D000077284:Abciximab